| Control | HL | CBT |
---|---|---|---|
Mean (SE) 95% CI | Mean (SE) 95% CI | Mean (SE) 95% CI | |
DASS-21 | |||
 Without MDD | |||
  Baseline | 40.27(3.3)33.7–46.8 | 35.76(3.8)28.2–43.3 | 39.92(3.1)33.8–46.0 |
  3 months | 26.90(7.1)12.7–41.1 | 31.10((8.2)14.8–47.4 | 30.40(6.6)17.4–43.6 |
 With MDD | |||
  Baseline | 45.49(3.2)39.1–51.8 | 46.51(3.1)40.4–52.6) | 43.75(3.3)37.3–50.2 |
  3 months | 37.34(6.9)23.7–51.0 | 49.38(6.6)36.3–52.5 | 36.65(7.0)22.7–50.7 |
IES-R | |||
 Without MDD | |||
  Baseline | 37.18(2.2)32.8–41.6 | 36.31(2.5)31.3–41.4 | 36.87(2.1)32.7–41.0 |
  3 months | 26.47(4.3)17.8–35.1 | 26.00(5.0)16.1–35.9 | 27.92(4.1)19.7–36.1 |
With MDD | |||
  Baseline | 41.11(2.1)35.9–44.3 | 41.56(2.1)37.3–45.8 | 38.95(2.2)34.5–43.4 |
  3 months | 39.56(4.2)31.3–47.8 | 42.97(4.2)34.6–51.3 | 32.53(4.4)23.8–41.2 |